Psychiatry Advisor: Psychedelic Drugs: Lessons From Ketamine and Psilocybin

Summary: Psychiatry Advisor explores the revitalization of psychedelic research for the treatment of mental health conditions, highlighting the therapeutic potential of ketamine, psilocybin, and MDMA. “Being realistic and avoiding hopes of a magic bullet, as well as building up a solid evidence base, could make psychedelics an excellent treatment opportunity for patients with psychiatric disorders,” explains Benjamin Williams of Psychiatry Advisor.

Originally appearing here.